Contineum Therapeutics (CTNM)
Nasdaq • CTNM • US21217B1008
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 28, 2026, ORTEX estimated 11.7% of free float sold short, 2.6 days to cover, cost to borrow 0.66%. Sign up for live short interest data.
Market Cap
422m USD | # 6278 in US
Volume
825.86k shares | 10.41m USD
Shares Outstanding
35.35m
Free Float Shares
85.13% | 30.1m
